Challenges and Future of Pharm D (Doctor of Pharmacy) Profession: Promising Career but with some reforms
Abstract
Pharmacy being a vast field has a lot to offer. However, it takes diligent work, proper planning, and the ability to choose the right option. Considering the value of a Pharm. D degree, it is recommended that the candidates pick the best college that focuses equally on theoretical as well as experiential postulates. After completion and during the course Pharm D candidate may provide the clinical pharmacy services in the hospital, work in the areas of Clinical research organizations (CRO), Pharmacovigilance, Pharmaco-economics, community services, research and academics. As a summary, it can be expected that the Pharmacists, i.e., Pharm D would play a major role in Indian health care system in future. This course will give an opportunity to pharmacists to work more prominently in Indian health care system. A poll conducted on LinkedIn Poll on the subject matter whether Pharm D (Doctor of Pharmacy) professionals have skill in 1. Prescribing Drugs 2. Drug interaction 3. Drug dose 4. Patient counselling has shown more positive responses, which is a good note for the future of Pharm D profession in India.
Downloads
References
2. Frequently asked questions about Pharm D [Internet]. pci.nic.in; 2011 Mar 13 [cited 2022 Mar 27]. Available from:
http://pci.nic.in/PDF-Files/question.PDF
3. Dooley M, Bogovic A, Carroll A, Cuell S, Galbraith K, Matthews H. SHPA standards of practice for clinical pharmacy. [Last cited on 2011 Jul 20]; Journal of Pharmacy Practice and Research. 2005;35(2):122-46.
4. Dooley M, Lyall H, Galbriath. SHPA standards of practice for clinical pharmacy.SHPA practice standards and definitions. 1996:2–11.
5. Joyce AW, Sunderland VB, Burrows S, McManus A, Howat P, Maycock B. Community pharmacy's role in promoting healthy behaviours. Journal of Pharmacy Practice and Research. 2007;37:42–44.
6. Peethaambaran Kunnathoor, Academics concerned about future of Pharm D and scope of its job opportunities, Pharmabiz, Education [Internet]. pharmabiz; 2022 [cited 2022 Mar 27]. Available from:
http://www.pharmabiz.com/NewsDetails
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM